Anti-Human HGF Recombinant Antibody(Rilotumumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human HGF Recombinant Antibody(Rilotumumab)

Anti-Human HGF Recombinant Antibody(Rilotumumab)

产品编号

YR1200

别名

科研级 Rilotumumab ( 利妥木单抗 ), Anti-HGF Recombinant Antibody, Research Grade Rilotumumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Rilotumumab ( 利妥木单抗 ), Anti-HGF Recombinant Antibody, Research Grade Rilotumumab
Catalog Number	YR1200
Molecular Name	Rilotumumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Rilotumumab (previously AMG102) is a human monoclonal antibody designed for the treatment of solid tumors. Rilotumumab was in development by Amgen, Inc. until in November 2014, when Amgen announced it had halted all clinical trials of the compound in advanced gastric cancer (including two Phase III studies) after one of the trials found an increase in the number of deaths in those who were taking rilotumumab and chemotherapy when compared to those who were only administered chemotherapy.
CAS Number	872514-65-3
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	HGF[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0